H1N1 vaccine: Phases II, III human trials begin today

The Serum Institute of India will begin phase II and III human clinical trials of the nasal spray vaccine against the H1N1 virus at two sites in Pune and three other centres on Monday. The virus has claimed 201 lives in Pune itself.Dr Prasad Kulkarni, director of clinical trials at the institute, told Newsline on Sunday that they had received the required approval from the Drug Controller General